Amneal Pharmaceuticals Inc. Earnings

Amneal Pharmaceuticals Inc.’s revenue jumped 18.4% since last year same period to $730.52Mn in the Q4 2024. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 3.99% jump in its revenue since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit jumped 68.49% since last year same period to $-31.08Mn in the Q4 2024. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated -19823.72% fall in its net profits since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit margin jumped 73.39% since last year same period to -4.25% in the Q4 2024. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated -19058.7% fall in its net profit margins since last 3-months.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.15 - a 17% jump from last quarter’s estimates.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.15.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) fell -14.29% since last year same period to 0.12 in the Q4 2024. This indicates that the Amneal Pharmaceuticals Inc. has generated -14.29% annual rate of fall in its earning per share (EPS) in the last 4 quarters.